| Dr Aaron Ray Stapley, DO | |
|
1050 S 500 W, Brigham City, UT 84302-4715 | |
| (435) 695-2727 | |
| Not Available |
| Full Name | Dr Aaron Ray Stapley |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 1050 S 500 W, Brigham City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427496918 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9806487-1204 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner Primary Care Physicians Arizona Llc | 6406020155 | 182 |
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
News Archive
New research shows a simple reason why even the most intelligent, complex brains can be taken by a swindler's story - one that upon a second look offers clues it was false.
Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated with Parkinson's disease and in response to treatments.
Researchers in Spain have identified plant extracts that may be of interest in the search for treatments of coronavirus disease 2019 (COVID-19) and serve as a basis for future chemical, in vivo, and clinical trials.
ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.
› Verified 2 days ago
| Entity Name | Banner Primary Care Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417238908 PECOS PAC ID: 6406020155 Enrollment ID: O20111115000898 |
News Archive
New research shows a simple reason why even the most intelligent, complex brains can be taken by a swindler's story - one that upon a second look offers clues it was false.
Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated with Parkinson's disease and in response to treatments.
Researchers in Spain have identified plant extracts that may be of interest in the search for treatments of coronavirus disease 2019 (COVID-19) and serve as a basis for future chemical, in vivo, and clinical trials.
ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Ray Stapley, DO Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (435) 695-2727 | Dr Aaron Ray Stapley, DO 1050 S 500 W, Brigham City, UT 84302-4715 Ph: (435) 695-2727 |
News Archive
New research shows a simple reason why even the most intelligent, complex brains can be taken by a swindler's story - one that upon a second look offers clues it was false.
Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated with Parkinson's disease and in response to treatments.
Researchers in Spain have identified plant extracts that may be of interest in the search for treatments of coronavirus disease 2019 (COVID-19) and serve as a basis for future chemical, in vivo, and clinical trials.
ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.
› Verified 2 days ago
Dr. Jeffrey R Lish, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 Fax: 877-395-5866 | |
Tye B Harrison, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W Hospital Rd, Brigham City, UT 84302 Phone: 435-734-2041 Fax: 435-723-8028 | |
Dr. Thomas Michael Matthews, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 W Hospital Rd, Brigham City, UT 84302 Phone: 435-734-2041 Fax: 435-723-8028 | |
Scott Mitchell Nagao, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 | |
Dr. James Robert Taylor, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 W Hospital Rd, Brigham City, UT 84302 Phone: 435-734-2041 Fax: 435-723-8028 | |
Dr. Michael C Shaw, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 Fax: 435-723-5240 | |
Dr. Brian C Dawson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 Fax: 435-723-5240 |